Vector Laboratories Announces Partnership With British Biotech Innovator Etcembly

Leader in manufacturing reagents and critical components for biomedical research to leverage Etcembly’s AI platform to optimize antibody engineering. NEWARK, Calif. -- Vector Laboratories, a manufacturing partner of reagents and critical components for the development and production of life sciences tools, diagnostics, and clinical-stage biotherapeutics, today announced a partnership with Etcembly, a British biotech innovator applying [...]

Elemental Machines and eLabNext Partner to Launch Free Add-on to Monitor and Record Environmental Laboratory Data

Elemental Machines and eLabNext launch a free add-on for real-time environmental monitoring to enhance lab data accessibility, compliance, and sample integrity. BOSTON, MA – Elemental Machines and eLabNext announced today that the Elemental Machines’ Connector add-on will now be available for free in the eLab Marketplace, eLabNext’s application library for extending and personalizing the functionality of their Digital Lab Platform. [...]

Revvity Wins Permanent Injunction Enforcing Agreements with Cloud Software Group

WALTHAM, Mass. -- Today, Revvity, Inc. (NYSE: RVTY) announced that the Massachusetts Superior Court has ruled in its favor and will issue a permanent injunction to enforce Revvity’s rights under its agreements with Cloud Software Group (CSG) related to the Spotfire® software. This ruling follows a preliminary injunction issued in April 2024, which will become permanent, ensuring uninterrupted access [...]

Opentrons Announces a Flex Proteomics Workstation for Automated Mass Spectrometry Sample Prep

LONG ISLAND CITY, N.Y. -- Opentrons Labworks, Inc. today introduced its Opentrons Flex® Proteomics Workstation, an automated system for common proteomics workflows, including preparing mass spectrometry (MS) samples at a cost significantly below the six-figure range common in proteomics automation. It automates steps such as protein digestion (SP3), quantification, labeling, and purification, streamlining processes that typically [...]

Biofidelity to launch Enspyre® technology at AGBT 2025

Enspyre is a next generation sequencing (NGS) preparation technology enabling higher sensitivity variant calling from a fraction of the data CAMBRIDGE, UK and RESEARCH TRIANGLE PARK, NORTH CAROLINA, USA -- Biofidelity, a leader in innovative genomic solutions, will present launch details for Enspyre®, a novel target enrichment technology with a broad spectrum of potential applications [...]

Biotage Appoints Chemoscience as Authorized Distributor in Singapore

Uppsala, Sweden: Biotage, a leading provider of innovative and sustainable solutions for drug discovery, development, and analytical testing, is pleased to announce the appointment of Chemoscience as its authorized distributor in Singapore. This strategic partnership underscores Biotage’s commitment to enhancing customer support and expanding its local presence in Singapore. Chemoscience, with its extensive expertise in [...]

Element Unveils AVITI24™ Innovation Roadmap Ahead of the Advances in Genome Biology and Technology (AGBT) 2025 Annual Meeting

The “High Dimensional Biology Unlocked” webinar showcases initial users and application of the first ever natively paired spatial multiomic platform Company to present five abstracts at the 2025 annual AGBT conference highlighting AVITI24’s capacity to unlock complex biological insights SAN DIEGO, Ca. --  Element Biosciences, Inc., a company democratizing access to advanced life science solutions, [...]

Nouryon today announced the expansion of its Kromasil® chromatography media manufacturing facility in Bohus, Sweden. Construction will begin in early 2025, and the start of production is expected in early 2027.

This expansion will double the facility’s capacity to meet the growing global demand for peptide-based drugs in the GLP-1 receptor agonist class. Kromasil® chromatography media, a key product in the Company's Consumer & Life Sciences segment, plays a crucial role for purifying novel peptide-based pharmaceuticals, including treatments for type 2 diabetes and obesity. “The rapidly [...]

Alamar Biosciences Launches Certified Service Provider Program to Expand Access to NULISA technology for Academic and Biopharmaceutical Researchers

FREMONT, Calif. -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is proud to announce the launch of its Certified Service Provider (CSP) Program, designed to expand access to its cutting-edge NULISA™ assays in academia and biopharmaceutical research. The newly established CSP Program provides researchers with a scalable, cost-effective way to [...]

Atrandi Biosciences Raises $25M Series A Led by Lux Capital

Atrandi Biosciences Raises $25M Series A Led by Lux Capital to Drive the Future of Single-Cell Multiomics with Semi-Permeable Capsule Technology Funding Led by Lux Capital, with participation from Vsquared Ventures, Practica Capital, Metaplanet and GRIDS Capital, to Drive Expansion in the U.S. and Scale Proprietary SPC Technology VILNIUS, LITHUANIA – Atrandi Biosciences, a life [...]

Access IBO on Knowledge Center